Phreesia(NYSE) PHR

Market Cap$643.68MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2019)-59%
5 Year-83%
1 Year-55%
1 Month-5%
Premium Feature
Moneyball Superscore
65/100
$10.20
-1.64%
-0.17Today
Phreesia last closing stock price
MetricPriceDate
Last closeUSD 10.372026-10-05
Phreesia stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+2.67%USD 10.102026-09-28
1 month-5.21%USD 10.942026-09-04
3 month-5.3%USD 10.952026-07-07
Year to date-38.71%USD 16.922025-12-31
1 year-55.44%USD 23.272025-10-03
3 year-43.21%USD 18.262023-10-06
5 year-82.71%USD 59.982021-10-06
Since inception-58.65%USD 25.082019-07-18

Phreesia Financials at a Glance

Market Cap

$643.68MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$507.79

Net Income (TTM)

$10.45

EPS (TTM)

$0.17

P/E Ratio

61.40

Dividend

$0.00

Beta (Volatility)

1.49 (Average)

Price

$10.20

Volume

200,419.02

Open

$10.46

Previous Close

$10.37

Daily Range

$10.21 - $10.57

52-Week Range

$7.77 - $24.25

Estimated Earnings Date

N/A

PHR News

Healthcare professional inspecting charts

Why Phreesia Stock Got Knocked Down Today

Eric VolkmanSep 8, 2026
Person about to receive a vaccine shot

Why Phreesia Stock Tumbled Today

Eric VolkmanSep 3, 2026
Healthcare professional inspecting charts

Why Phreesia Stock Got Clocked Today

Eric VolkmanMay 20, 2026
Red down arrow on a black backdrop of tickertape prices.

Why Phreesia Stock Flopped Today

Rich SmithMar 31, 2026
Two people participating in a telehealth session

Why Phreesia Stock Plummeted by 23% Today

Eric VolkmanDec 9, 2025
institutional.png

Capricorn Fund Loads Up on Phreesia (PHR) With a 484,000 Share Purchase

Cory RenauerOct 27, 2025
featured-earnings-leadership-highlights.png

Phreesia Reports First Net Income Gain

Motley Fool Markets TeamSep 4, 2025
Foolcom-Featured.png

Phreesia Posts 15% Revenue Gain in Q2

Motley Fool Markets TeamSep 4, 2025
Page 1

PHR: Motley Fool Moneyball Superscore

65

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Phreesia

Phreesia, Inc. engages in the provision of patient check-in solutions for medical practices. The firm offers appointments, clinical support, integration, registration, patient activation, analytics and reports, revenue cycle, patient surveys, and privacy and security products. Its solutions include health systems, multi-specialty, and federally qualified health centers (FQHCs). The company was founded by Chaim Indig and Evan Roberts in January 2005 and is headquartered in Wilmington, DE.

Industry

Health Care Technology

Sector

Health Care

Employees

1,789

CEO

Chaim Indig

Website

www.phreesia.com

PHR Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

3.12%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

1.63%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

$643.68MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

62.07M

Volume

200.42K

Avg. Volume

747.88K

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Phreesia Performance Analysis

Phreesia annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-01-31USD 280,910,00031.7%
20242024-01-31USD 356,299,00026.8%
20252025-01-31USD 419,813,00017.8%
20262026-01-31USD 480,591,00014.5%
Phreesia annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-01-31USD -3.3641.8%
20242024-01-31USD -2.51-25.3%
20252025-01-31USD -1.02-59.5%
20262026-01-31USD 0.04N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2026YOY CHG

Revenue

$129.46

+1.1%

Gross Profit

$76.17

+1.1%

Gross Margin

58.84%

+1.0%

Market Cap

$643.68MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$0.37

N/A

Employees

1,789

N/A

Net Income

$1.92

+2.9%

EBITDA

$21.15

+3.4%

Quarterly Fundamentals

Name
Q3 2026YOY CHG

Total Cash

$140.89

+26.9%

Total Debt

$67.95

+5.3%

Accounts Receivable

$89.41

+1.2%

Inventory

$0.00

N/A

Long Term Debt

$61.84

+13.0%

Short Term Debt

$6.11

+0.8%

Return on Assets

1.98%

-0.3%

Return on Invested Capital

-32.48%

+0.9%

Free Cash Flow

$17.84

+1.4%

Operating Cash Flow

$18.33

+1.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,828.74+0.01%
^DJIDJI
$51,532.64+0.01%
^IXICNASDAQ
$27,658.12+0.01%
BTCBitcoin
$85,726.00+0.00%

Questions About PHR

What is the current price of Phreesia?

Phreesia is trading at $10.21 per share.

What is the 52-week range for Phreesia?

Over the past 52 weeks, Phreesia has traded between $7.77 and $24.25.

How much debt does Phreesia have?

As of the most recent reporting period, Phreesia reported total debt of $67.95M.

How much cash does Phreesia have on hand?

Phreesia reported $72.95M in cash and cash equivalents in its most recent financial results.

What is Phreesia’s dividend yield?

Phreesia does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services